Two Stocks To Ponder On: Neos Therapeutics, Inc. (NASDAQ:NEOS), Avery Dennison Corporation (NYSE:AVY)

stock recommendation

Neos Therapeutics, Inc. (NASDAQ:NEOS)

Neos Therapeutics, Inc. (NASDAQ:NEOS) closed at $1.58 on the last trading session with an decrease of -4.82%, whereas, it previously closed at $1.66. The company has a market capitalization of $78.57 Million. The company traded shares of 144605 on the trading day while its three month average volume stands at 171.25 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) produced diluted EPS of -0.88. The EPS estimate for next year as estimated by analysts is at -0.13 while EPS for next quarter is estimated at -0.09. Earnings per Share growth for this year is reported at 39.8, while the analysts estimated the EPS growth for next year at -0.13% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Neos Therapeutics, Inc. (NASDAQ:NEOS) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Neos Therapeutics, Inc. (NASDAQ:NEOS) stands at 1.35 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Neos Therapeutics, Inc. (NASDAQ:NEOS) are reported at 0.9 and 1.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Neos Therapeutics, Inc. (NASDAQ:NEOS) stands at -47.7, 930.5 and -73 respectively

The trailing twelve month Revenue of Neos Therapeutics, Inc. (NASDAQ:NEOS) is reported at 58.2 Million with income of -33400000. The outstanding shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) are 49.73 Million. The institutional Ownership of the shares of 46.4 stands at 0.80%, this figure is decreased -0.04 in the last six months. The insider ownership for the shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) is ticked at 10.03%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Neos Therapeutics, Inc. (NASDAQ:NEOS) is the Mean Target Price estimated by the analysts which stands at 7. The 52 week high of Neos Therapeutics, Inc. (NASDAQ:NEOS) is placed at 3.62 and 52 week low is standing at 1.13.

Performance wise the shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) rose up 2.6% for the week, it also rise 15.33% for the monthly performance, while for the quarter it went up -7.06%. The shares decrease -11.73% for the half year and plummeted for the Year-To-Date performance. The shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) shrinked -39% for the yearly performance.

Avery Dennison Corporation (NYSE:AVY)

Avery Dennison Corporation (NYSE:AVY) closed at $133.89 on the last trading session with an increase of 0.32%, whereas, it previously closed at $133.46. The company has a market capitalization of $11.25 Billion. The company traded shares of 414982 on the trading day while its three month average volume stands at 499.87 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Avery Dennison Corporation (NYSE:AVY) produced diluted EPS of 2.77. The EPS estimate for next year as estimated by analysts is at 7.05 while EPS for next quarter is estimated at 1.7. Earnings per Share growth for this year is reported at 5.5, while the analysts estimated the EPS growth for next year at 7.05% and Earnings growth for next 5 years stands at 10.57% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 17.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Avery Dennison Corporation (NYSE:AVY) is at 48.28 while the forward p/e is at 19. The P/S or Price to Sales ratio of Avery Dennison Corporation (NYSE:AVY) stands at 1.59 and Price to Book or P/B for the most recent quarter stands at 10.63. The Price to Free Cash Flow ratio or P/FCF is reported at 34.65. The quick ratio and the current ratio of Avery Dennison Corporation (NYSE:AVY) are reported at 0.7 and 1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Avery Dennison Corporation (NYSE:AVY) stands at 4.5, 23.4 and 19.8 respectively

The trailing twelve month Revenue of Avery Dennison Corporation (NYSE:AVY) is reported at 7.07 Billion with income of 239.1 Million. The outstanding shares of Avery Dennison Corporation (NYSE:AVY) are 84 Million. The institutional Ownership of the shares of 92.1 stands at 0.80%, this figure is decreased -0.7 in the last six months. The insider ownership for the shares of Avery Dennison Corporation (NYSE:AVY) is ticked at 0.3%, the figure is plummeted -31.46% in the last six months.

Some other important financial aspects to be discussed here for Avery Dennison Corporation (NYSE:AVY) is the Mean Target Price estimated by the analysts which stands at 128.56. The 52 week high of Avery Dennison Corporation (NYSE:AVY) is placed at 134.56 and 52 week low is standing at 82.89.

Performance wise the shares of Avery Dennison Corporation (NYSE:AVY) rose up 0.44% for the week, it also rise 18.59% for the monthly performance, while for the quarter it went down 21.83%. The shares increase 29.95% for the half year and flew up for the Year-To-Date performance. The shares of Avery Dennison Corporation (NYSE:AVY) grew 45.53% for the yearly performance.